Part, Chapter, Paragraph
1 II, 5. 1. 1| accumulation that drives towards progression to the disease. Further
2 II, 5. 2. 6| been shown to slow atheroma progression, and/or induce regression,
3 II, 5. 4. 1| rapidly developing with the progression of the disease include an
4 II, 5. 4. 5| fat accumulation drives progression to the disease.~Further
5 II, 5. 4. 6| treatment) can modify the progression of the disease. An early
6 II, 5. 4. 7| monitor the status and the progression of the disease.~ ~
7 II, 5. 5. 3| characterized by a lack of disease progression, (b) progressive-relapsing
8 II, 5. 5. 3| characterized by continuing progression; (c) secondary-progressive
9 II, 5. 5. 3| initial RR course followed by progression with or without occasional
10 II, 5. 5. 3| MS (PP-MS), disease with progression from onset with plateaus
11 II, 5. 5. 3| attacks and halting further progression of the disease. Based on
12 II, 5. 5. 3| retention that can reduce the progression of the disease, yet many
13 II, 5. 5. 3| isolated syndromes, secondary progression, direct comparison of immunomodulatory
14 II, 5. 5. 3| al (2000): Relapses and progression of disability in multiple
15 II, 5. 5. 3| clinical predictors and progression of irreversible disability
16 II, 5. 5. 3| markedly increase with disease progression, and iii) the majority of
17 II, 5. 5. 3| symptoms, but do not halt the progression of the disease.~ ~Policies~
18 II, 5. 5. 3| of Parkinson’s disease: progression and mortality at 10 years.
19 II, 5. 5. 3| 1967): Parkinsonism: onset, progression and mortality. Neurology:
20 II, 5. 6. 3| Dougados et al, 1992). Progression of OA is accelerated by
21 II, 5. 6. 3| from the figures of the progression of radiological osteoarthritis
22 II, 5. 6. 3| The incidence and rate of progression increases with age.~ ~Prevalence~ ~
23 II, 5. 6. 3| predictor of the development and progression of radiographic OA (Table
24 II, 5. 6. 3| risk of the development and progression of knee OA (Petersson and
25 II, 5. 6. 3| hand, knee and hip and for progression in the knee and hip (Woolf,
26 II, 5. 6. 3| factors for incidence and progression of osteoarthritis of the
27 II, 5. 6. 3| 1980’s most had significant progression over 10 years with few being
28 II, 5. 7. 1| or delay kidney disease progression and the resulting cardiovascular
29 II, 5. 7. 1| detection can prevent or delay progression to end stage renal disease (
30 II, 5. 7. 1| Figure 5.7.1. Development and progression of CKD.~ ~ESRD and the resulting
31 II, 5. 7. 3| 2006a) the relative risk for progression from CKD stages 3 or 4 to
32 II, 5. 8. 5| prevalence of COPD and its progression to more severe stages. Main
33 II, 5. 14. 2| decades. Also, the rate of progression of the disease slows down
34 II, 5. 14. 3| develop caries. The rate of progression of the disease slows down
35 II, 5. 14. 3| implicated as a co-factor in the progression of diabetes, some cardiovascular
36 II, 6. 3. 4| increases the likelihood of progression, while preventive therapy
37 II, 6. 3. 6| reported given the slow progression of the disease over many
38 II, 9. 4. 3| environment can help reduce the progression of disability (WHO, 1999).
39 II, 9. 4. 5| skill development and career progression. There will clearly be opportunities
40 III, 10. 2. 1| Furthermore, relative trends in progression from STP into and from smoking
41 III, 10. 2. 1| start drinking and slow progression towards drinking larger
42 III, 10. 2. 1| and slows or reverses the progression of existing lesions. Dramatic
43 III, 10. 2. 2| been shown to slow atheroma progression, and/or to induce regression,
44 IV, 12. 2 | treatment) can modify the progression. Early diagnosis and/or
45 IV, 12. 2 | start drinking and slow progression towards drinking larger
